ORBI-PHARMA INTERNATIONAL
0899.434.280 · rovalta.com · 22/09/2026
ORBI-PHARMA INTERNATIONAL
Overview
What does ORBI-PHARMA INTERNATIONAL do?
ORBI-PHARMA INTERNATIONAL is a Private limited company incorporated in 2008. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Bierbeek.
3360 Bierbeek · FlandreSee on map
Joint committees (1)
- 218
Trend over 16 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||||||||||||||||||
| Gross margin | 148,2 k € | +19.4% | 124,1 k € | -7.0% | 133,5 k € | -62.4% | 354,6 k € | +19.0% | 298,1 k € | +20.7% | 247 k € | +8.4% | 227,8 k € | +16.4% | 195,7 k € | +30.3% | 150,1 k € | -42.3% | 260,3 k € | +18.3% | 220,1 k € | -16.6% | 263,9 k € | +11.4% | 236,9 k € | +56.6% | 151,3 k € | +287% | 39,1 k € | +20.6% | 32,4 k € |
| EBITDA | -16,6 k € | +71.3% | -57,9 k € | +44.9% | -105 k € | -210% | 95,3 k € | +86.0% | 51,2 k € | +59.8% | 32,1 k € | -19.8% | 40 k € | +98.9% | 20,1 k € | +135% | -56,9 k € | -197% | 58,9 k € | +149% | 23,6 k € | -70.4% | 80 k € | -38.3% | 129,7 k € | +22.5% | 105,9 k € | +681% | 13,6 k € | -36.1% | 21,2 k € |
| Operating result | -30 k € | +58.3% | -71,9 k € | +46.8% | -135,1 k € | -295% | 69,1 k € | +162% | 26,4 k € | +240% | 7,8 k € | -31.1% | 11,3 k € | +334% | -4,8 k € | +94.9% | -93,6 k € | -421% | 29,2 k € | +298% | -14,8 k € | -131% | 47,5 k € | -47.5% | 90,5 k € | +4.6% | 86,5 k € | +2134% | 3,9 k € | -12.0% | 4,4 k € |
| Net result | -42,4 k € | +47.7% | -81,1 k € | +35.1% | -124,8 k € | -409% | 40,4 k € | +145% | 16,5 k € | +303% | 4,1 k € | -14.4% | 4,8 k € | +134% | -14,2 k € | +86.2% | -102,3 k € | -684% | 17,5 k € | +180% | -22 k € | -196% | 22,9 k € | -57.3% | 53,5 k € | -12.0% | 60,8 k € | +1441% | 3,9 k € | +3255% | 117,7 € |
| Balance sheet | |||||||||||||||||||||||||||||||
| Equity | -247,3 k € | -20.7% | -204,9 k € | -65.4% | -123,9 k € | -13220% | 944 € | +102% | -39,4 k € | +29.4% | -55,9 k € | +6.8% | -60 k € | +7.4% | -64,8 k € | -28.0% | -50,6 k € | -198% | 51,7 k € | -55.9% | 117,2 k € | -15.8% | 139,2 k € | +19.7% | 116,3 k € | +85.2% | 62,8 k € | +281% | 16,5 k € | +31.5% | 12,5 k € |
| Total assets | 161,7 k € | -8.8% | 177,3 k € | -33.9% | 268,2 k € | -41.7% | 460,3 k € | -12.7% | 527 k € | +18.5% | 444,6 k € | +6.2% | 418,8 k € | -15.4% | 495,2 k € | -10.0% | 550,4 k € | -25.7% | 740,7 k € | +2.5% | 722,7 k € | +36.7% | 528,6 k € | +8.1% | 489,1 k € | +23.4% | 396,5 k € | +171% | 146,2 k € | +38.0% | 106 k € |
| Cash | 1 k € | -67.0% | 3,1 k € | -60.6% | 7,9 k € | -83.7% | 48,2 k € | +564% | 7,3 k € | +665% | 947,8 € | -85.9% | 6,7 k € | -23.9% | 8,8 k € | +730% | 1,1 k € | -96.2% | 28,3 k € | +1237% | 2,1 k € | -42.9% | 3,7 k € | -92.0% | 46,7 k € | +223% | 14,4 k € | +2319% | 597 € | -98.7% | 46,8 k € |
| Debts | 408,9 k € | +7.0% | 382,2 k € | -2.5% | 392,1 k € | -14.3% | 457,6 k € | -19.0% | 564,7 k € | +13.2% | 498,8 k € | +4.8% | 475,9 k € | -14.4% | 556,2 k € | -7.1% | 598,9 k € | -12.7% | 686,4 k € | +13.5% | 604,8 k € | +55.5% | 388,9 k € | +5.1% | 369,9 k € | +10.8% | 333,7 k € | +157% | 129,8 k € | +59.0% | 81,6 k € |
| Other | |||||||||||||||||||||||||||||||
| Workforce | – | 2,6 ETP | -49.0% | 5,1 ETP | -99.0% | 505,0 ETP | +11377% | 4,4 ETP | -2.2% | 4,5 ETP | +28.6% | 3,5 ETP | 0.0% | 3,5 ETP | -25.5% | 4,7 ETP | +4.4% | 4,5 ETP | 0.0% | 4,5 ETP | +9.8% | 4,1 ETP | +32.3% | 3,1 ETP | +82.4% | 1,7 ETP | +30.8% | 1,3 ETP | +550% | 0,2 ETP | |
Board of directors
Seen on filing of 30/06/2025 · 2 active · 7 ended
Active mandates
Ended mandates
Financials
Full financial information
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/07/2024 | 01/07/2023 | 01/07/2022 | 01/07/2021 | 01/07/2020 | 01/07/2019 |
| Closing of the financial year | 30/06/2025 | 30/06/2024 | 30/06/2023 | 30/06/2022 | 30/06/2021 | 30/06/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 27/02/2026 | 27/02/2025 | 16/02/2024 | 27/01/2023 | 27/01/2022 | 28/01/2021 |
| General meeting | 06/12/2025 | 06/12/2024 | 06/12/2023 | 06/12/2022 | 06/12/2021 | 07/12/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Looking for more information about this company?
Try for 7 daysAnnual accounts filings
16 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 30/06/2025 | 06/12/2025 | 27/02/2026 | Dutch | |
| Abridged model | 30/06/2024 | 06/12/2024 | 27/02/2025 | Dutch | |
| Abridged model | 30/06/2023 | 06/12/2023 | 16/02/2024 | Dutch | |
| Abridged model | 30/06/2022 | 06/12/2022 | 27/01/2023 | Dutch | |
| Abridged model | 30/06/2021 | 06/12/2021 | 27/01/2022 | Dutch | |
| Abridged model | 30/06/2020 | 07/12/2020 | 28/01/2021 | Dutch | |
| Abridged model | 30/06/2019 | 06/12/2019 | 24/01/2020 | Dutch | |
| Abridged model | 30/06/2018 | 06/12/2018 | 13/12/2018 | Dutch | |
| Abridged model | 30/06/2017 | 09/08/2017 | 21/12/2017 | Dutch | |
| Abridged model | 30/06/2016 | 06/12/2016 | 23/12/2016 | Dutch | |
| Abridged model | 30/06/2015 | 07/12/2015 | 29/01/2016 | Dutch | |
| Abridged model | 30/06/2014 | 06/12/2014 | 06/02/2015 | Dutch | |
| Abridged model | 30/06/2013 | 06/12/2013 | 13/02/2014 | Dutch | |
| Abridged model | 30/06/2012 | 06/12/2012 | 11/02/2013 | Dutch | |
| Abridged model | 30/06/2011 | 28/03/2012 | 05/04/2012 | Dutch | |
| Abridged model | 30/06/2010 | 06/12/2010 | 07/12/2010 | Dutch |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Seen on filing of 30/06/2025 · 2 active · 7 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
- Mandates07/05/2026ONTSLAGEN - BENOEMINGEN - WIJZIGING RECHTSVORM
- Mandates01/03/2013ONTSLAGEN - BENOEMINGEN
- Other15/03/2011STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
- Mandates09/12/2010SIEGE SOCIAL - ADRESSE AUTRE QUE SIEGE SOCIAL - CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS
- Registered office07/12/2009SIEGE SOCIAL
- Registered office30/04/2009SIEGE SOCIAL - ADRESSE AUTRE QUE SIEGE SOCIAL
- Other25/07/2008RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
Source: Belgian Official Gazette
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025-42,4 k €↑
- 2024Annual accounts 2024-81,1 k €↑
- 2023Annual accounts 2023-124,8 k €↓
- 2022Annual accounts 202240,4 k €↑
- 2021Annual accounts 202116,5 k €↑
- 2020Annual accounts 20204,1 k €↓
- 2019Annual accounts 20194,8 k €↑
- 2018Annual accounts 2018-14,2 k €↑
- 2017Annual accounts 2017-102,3 k €↓
- 2016Annual accounts 201617,5 k €↑
- 2015Annual accounts 2015-22 k €↓
- 2014Annual accounts 201422,9 k €↓
- 2013Annual accounts 201353,5 k €↓
- 2012Annual accounts 201260,8 k €↑
- 2011Annual accounts 20113,9 k €↑
- 2010Annual accounts 2010117,7 €
- 23/07/2008IncorporationPrivate limited company